Organizer: BioBuzz
-

Biotech, Borders, and Security: Reshoring the Future of U.S. Manufacturing
As global tensions, tariffs, and foreign ownership controls reshape the biotech landscape, one question demands action: How will we secure America’s bioeconomy? Join Maryland’s leading voices in government, biomanufacturing, and economic development for a dynamic forum exploring how workforce, policy, and innovation can strengthen the nation’s biomanufacturing future. Together, we’ll break down how onshoring, federal…
-
From Lab to GMP: Building a Clinical-Ready Biotech
How early-stage teams avoid rework, delays, regulatory missteps — and the loss of investor confidence PLUS – A BioBuzz Philly Startup Showcase This event is part of BioBuzz’s Insights to Impact Series, a curated program designed exclusively for life sciences industry leaders and ecosystem builders. Our guest list is intentionally built to foster a high-quality,…
-
What’s the Buzz?! A Nexus of Innovation
What’s the Buzz?! A Nexus of Innovation In this episode of What’s the Buzz?!, we’re joined by Amy Adams, Executive Director of Nexus234 Innovation District, Northern Virginia’s first innovation district. Ms. Adams co-led the district from ideation through implementation, working closely with local government, higher education, and the regional business community to drive economic growth…
-

Scaling into Clinical
The life sciences industry is bursting with innovation. Novel therapies, technologies, and delivery models are emerging constantly, promising better patient outcomes and new commercial opportunities. What often limits their impact is not the quality of the science, but the ability to move discoveries methodically into the clinic. Companies frequently face challenges navigating regulatory pathways, designing…
-
What’s the Buzz?! Designing the Next Innovation Ecosystem
What’s the Buzz?! Designing the Next Innovation Ecosystem In this episode of What’s the Buzz?!, we’re joined by Roy Zwahlen, a strategic leader working at the intersection of innovation, execution, and ecosystem design in the life sciences. Drawing on his roles as Interim Executive Director, Chief Strategy Officer at Eshelman Innovation and Associate Dean for…
